MetaVia Inc. (MTVA) vs NeuroOne Medical Technologies Corporation (NMTC)
A side-by-side comparison of MetaVia Inc. and NeuroOne Medical Technologies Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MTVA
MetaVia Inc.
$1.47HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT
NMTC
NeuroOne Medical Technologies Corporation
$1.15HealthcareDelayed quote: Oct 6, 2026, 11:53 AM EDT
Total return — MTVA vs NMTC
growth of $100 · dividends reinvested · last 2yMTVA -94.5% (-76.5%/yr)NMTC -80.1% (-55.4%/yr)NMTC compounded faster over this window
MTVA NMTC
MTVA vs NMTC: by the numbers
- •NMTC is the larger company ($10M vs $10M market cap).
- •Both run net losses; MTVA's is the smaller (0.00% vs -71.51% net margin).
Metrics side by side
Valuation
| Metric | MTVA | NMTC |
|---|---|---|
| P/S ratio | N/A | 1.00 |
| P/B ratio | 1.42 | 2.66 |
Profitability
| Metric | MTVA | NMTC |
|---|---|---|
| Gross margin | 0.00% | 67.30% |
| Operating margin | 0.00% | -34.94% |
| Net margin | 0.00% | -71.51% |
| ROE | -211.76% | -189.76% |
| ROIC | -215.61% | -183.45% |
Growth (annualized)
| Metric | MTVA | NMTC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 37.21% |
| Total return CAGR (5Y) | N/A | -46.02% |
Go deeper
Dig into the metrics
MetaVia ROENeuroOne Medical Technologies ROEMetaVia operating marginNeuroOne Medical Technologies operating marginMetaVia revenue growthNeuroOne Medical Technologies revenue growthMetaVia free cash flowNeuroOne Medical Technologies free cash flow
MetaVia & NeuroOne Medical Technologies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.